Recombinant Parathyroid Hormone Versus Usual Care: Do the Outcomes Justify the Cost?
Crossref DOI link: https://doi.org/10.1007/s00268-017-4248-4
Published Online: 2017-09-19
Published Print: 2018-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Chomsky‐Higgins, Kathryn H.
Rochefort, Holly M.
Seib, Carolyn D.
Gosnell, Jessica E.
Shen, Wen T.
Duh, Quan‐Yang
Suh, Insoo
Version of Record valid from 2017-09-19
License valid from 2017-09-19